ULTRASTRUCTURAL LOCALIZATION OF IMMUNO- REACTIVE FUCOSYLCERAMIDE FUCOSYLCERAMIDE IN NORMAL AND ADENOCARCINOMA CELLS
暂无分享,去创建一个
[1] H. Kitagawa,et al. Immunoreactive fucosylceramide as a B-cell differentiation marker. , 1993, Immunology letters.
[2] Y. Kawabata,et al. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung. , 1992, Cancer research.
[3] H. Ishihara,et al. Establishment and characterization of a mouse monoclonal anti-fucosylceramide antibody, PC47H. , 1991, Cancer research.
[4] S. Hakomori,et al. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.
[5] T. Tsuruo,et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. , 1988, Cancer research.
[6] S. Hakomori,et al. Novel fucolipids of human adenocarcinoma: monoclonal antibody specific for trifucosyl Ley (III3FucV3FucVI2FucnLc6) and a possible three-dimensional epitope structure. , 1986, The Journal of biological chemistry.
[7] S. Hakomori,et al. Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. , 1984, The Journal of biological chemistry.